Letrozole as an adjunct treatment in antagonist cycles that previously failed in poor responders.

Kaçar, Melek Turaç; Biler, Alper; Köse, Can; Sahin Güleç, Ebru; Demir, Ahmet

Kaçar, Melek Turaç; Biler, Alper; Köse, Can; Sahin Güleç, Ebru; Demir, Ahmet.

Affiliation

Kaçar MT; University of Health Sciences Tepecik Education and Research Hospital, Izmir, Turkey.
Biler A; University of Health Sciences Tepecik Education and Research Hospital, Izmir, Turkey. bileralper@gmail.com.
Köse C; University of Health Sciences Tepecik Education and Research Hospital, Izmir, Turkey.
Sahin Güleç E; University of Health Sciences Tepecik Education and Research Hospital, Izmir, Turkey.
Demir A; University of Health Sciences Tepecik Education and Research Hospital, Izmir, Turkey.

Ginekol Pol ; 93(4): 267-272, 2022.

Article in En | MEDLINE | ID: mdl-34263913

Subject(s)

Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Pregnancy; Female; Humans; Letrozole; Gonadotropins; Pregnancy Rate; Fertilization in Vitro; Hormone Antagonists; Ovulation Induction

Key words

antagonist cycle; diminished ovarian reserve; letrozole; ovarian stimulation; poor response

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gonadotropin-Releasing Hormone / Follicle Stimulating Hormone Type of study: Prognostic_studies Limits: Female / Humans / Pregnancy Language: En Journal: Ginekol Pol Year: 2022 Document type: Article Affiliation country: Turkey Country of publication: Poland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google